Tranylcypromine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tranylcypromine. Educational only — not medical advice.
Labeled uses
Tranylcypromine sulfate tablets are indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants. Tranylcypromine sulfate tablets are not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions [see Contraindications (4), Warnings and Precautions (5) , and Drug Interactions (7)].
Source: FDA labeling via NIH DailyMed (set 6a0b609b…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.